Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Azienda Ospedaliero-Universitaria di Parma
Brigham and Women's Hospital
Institut Bergonié
OncoNano Medicine, Inc.
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
University of Colorado, Denver
Washington University School of Medicine
Trishula Therapeutics, Inc.
Seagen Inc.
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Eastern Cooperative Oncology Group
Ludwig Institute for Cancer Research
Incyte Corporation
Hospices Civils de Lyon
Celgene
Tocagen Inc.
European Association of Urology Research Foundation
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Rutgers, The State University of New Jersey
Valerio Therapeutics
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
University of Utah
Netherlands Open University
Titan Pharmaceuticals
Case Comprehensive Cancer Center
Novacea